Advertisement

Topics

Excipient makers want to be the ‘first second’ in novel ingredient development, say execs

09:26 EDT 17 May 2018 | in-PharmaTechnologis

An improved relationship between drugmakers and excipient suppliers could help drive development in the novel inactive ingredient sector, says industry expert.

Original Article: Excipient makers want to be the ‘first second’ in novel ingredient development, say execs

NEXT ARTICLE

More From BioPortfolio on "Excipient makers want to be the ‘first second’ in novel ingredient development, say execs"

Advertisement
Quick Search
Advertisement
Advertisement